You don't need to be signed in to read BMJ Blogs, but you can register here to receive updates about other BMJ products and services via our site.

CDKN2A is the main susceptibility gene in Italian pancreatic cancer families

5 Mar, 12 | by hqqu

Pancreatic adenocarcinoma (PC) is the deadliest among common cancers. Because PC progresses rapidly, identifying individuals with a high genetic risk of developing PC is critical to better define emerging strategies for the detection of  early lesions. PC is familial in roughly 10% of patients. Germline mutations in CDKN2A, the major melanoma susceptibility gene, are detected in 30-40% of patients with the melanoma-PC and the familial atypical multiple mole melanoma-PC syndromes, but are considered to play a minor role in familial PC (FPC). Our study identified CDKN2A mutations in 31% of patients with FPC, suggesting that CDKN2A is the main susceptibility gene in Italian FPC families, although melanoma is not a feature of FPC and was not recorded in these patients or their families. The mutation frequency ranged from 20% in FPC families with two affected members to 50% in families with three. Our findings  may be of  value to the purposes of identifying the best candidates for  future PC screening trials in Italy. (By Dr Paola Ghiorzo, http://jmg.bmj.com/content/49/3/164 )

By submitting your comment you agree to adhere to these terms and conditions
You can follow any responses to this entry through the RSS 2.0 feed.
JMG blog homepage

JMG Contact

Research developments and evidence-based medical genetics. Visit site

Latest from Journal of Medical Genetics

Latest from Journal of Medical Genetics